Your town. Your news. Your take.

Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

 
Advertisment

AstraZeneca Group News

News on AstraZeneca Group continually updated from thousands of sources around the net.

1 hr ago | World of Psychology

Seroquel XR Gets Additional Approvals

Helping to extend Seroquel's existing reach, AstraZeneca, its maker, has received U.S. Food and Drug Administration approval to market it as an effective treatment not only for mania associated with bipolar ...

Comment?

Related Topix: Seroquel, Quetiapine (generic), Medicine, Medication, Food and Drug Administration, Biotech, Healthcare Industry

17 hrs ago | Boston Globe

1 killed, 1 hurt in accident at job site

The lift at the AstraZeneca campus tipped over when the men were about 30 feet in the air.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Hospital Administration

Fri Oct 10, 2008

UnionLeader.com

Nashua man killed in Mass. construction accident

A Nashua, N.H., man was killed and another construction worker seriously injured when a hydraulic lift tipped over at a project at a pharmaceutical company yesterday, according to police.

Comment?

Related Topix: Nashua, NH, Nashua Metro, Biotech, Medicine, Healthcare Industry

WMUR-TV Manchester

Nashua Man Killed In Industrial Incident In Massachusetts

One worker was killed and another injured Friday in an industrial incident at a building in Waltham, Mass.

Comment?

Related Topix: Nashua, NH, Nashua Metro, Biotech, Medicine, Healthcare Industry

WebWire

FDA Approves AstraZeneca's Seroquel XR for the Treatment of...

AstraZeneca today announced that the US Food and Drug Administration has approved once-daily SEROQUEL XR Extended-Release Tablets for the acute treatment of the depressive episodes associated with bipolar ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Seroquel, Quetiapine (generic), Food and Drug Administration, Medication, Bipolar Disorder, Health, Lithium (generic), Eskalith, Lithobid

PR-inside.com

Zacks Analyst Blog Highlights: AstraZeneca PLC, Phase Forward,...

Zacks Analyst Blog Highlights: AstraZeneca PLC, Phase Forward, Omnicom Group, Acorda Therapeutics and Digital River, Inc.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Software, Digital River, Consulting, Omnicom Group, Advertising, Acorda Therapeutics

Thu Oct 09, 2008

Washington Business Journal

Heartburn, insomnia lead drugmaker Web sites

Popular prescriptions for heartburn, diabetes and insomnia led people to pharmaceutical company Web sites in the second quarter, says a report from comScore Inc.

Comment?

Related Topix: Heartburn, Medicine, Insomnia, Health, Diabetes, Biotech, Healthcare Industry

Wed Oct 08, 2008

Buffalo Business First

Cancer network study includes RPCI

Roswell Park Cancer Institute will receive funding to enable additional studies on anti-cancer drugs.

Comment?

Related Topix: Biotech, Abraxis Bioscience, Medicine, Healthcare Industry

The Motley Fool

Eli Lilly's Risky Gamble

At $6.5 billion , ImClone isn't coming all that cheap, but Eli Lilly really needs ImClone's Erbitux and pipeline and is clearly willing to pay for it.

Comment?

Related Topix: Biotech, Medicine, ImClone Systems, Healthcare Industry, Bristol Myers Squibb

Tue Oct 07, 2008

The Hindu

CTS inaugurates Budapest centre

CHENNAI: Cognizant Technology Solutions, a global consulting, technology and business process services provider has inaugurated its delivery centre in Budapest, Hungary.

Comment?

Related Topix: Hungary, World News, Cognizant Technology Solutions, Computers, IT Services, Software, Biotech, Medicine, Healthcare Industry

PR-inside.com

NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies

The NCCN studies will evaluate ABRAXANE in the treatment of breast, non-small cell lung, head and neck, melanoma and ovarian cancers.

Comment?

Related Topix: Biotech, Abraxis Bioscience

Medical News Today

New Review Supports Use Of Formoterol In Children And Adolescents With Asthma

Main Category: Respiratory / Asthma Also Included In: Pediatrics / Children's Health ; Regulatory Affairs / Drug Approvals Article Date: 07 Oct 2008 - 4:00 PDT A new review of the long acting beta2-agonist ...

Comment?

Related Topix: Foradil, Formoterol (generic), Medication, Asthma, Health, Biotech, Healthcare Industry

Sun Oct 05, 2008

M2.com

MedImmune licenses reverse genetics technology to Japan's BIKEN for...

MedImmune licenses reverse genetics technology to Japan's BIKEN for use in influenza vaccine development M2Europharma on Monday, 29 September 2008 at 19:58 GMT 29 September 2008 MedImmune, wholly-owned by ...

Comment?

Related Topix: Biotech, Medicine, Influenza, Health, Bird Flu, Epidemic, Natural Disasters

Fri Oct 03, 2008

Seeking Alpha

Palatin Technologies, Inc. F4Q08 Call Transcript

Palatin Technologies, Inc. F4Q08 Earnings Call September 30, 2008 11:00 am ET Executives Carl Spana, Ph.D. - " President and Chief Executive Officer Stephen T. Wills - Chief Financial Officer Trevor Hallam, ...

Comment?

Related Topix: Corporate / Securities Law, Law, Biotech, Medicine, Healthcare Industry

Wed Oct 01, 2008

Legal Times

Federal Judge Certifies Two Nationwide Classes in Wholesale Drug Pricing Case

A federal judge in Boston certified two nationwide classes and set the stage for two more trials in the massive, multidistrict wholesale drug pricing case against AstraZeneca and Bristol-Myers Squibb Co.

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry, Bristol Myers Squibb, Massachusetts, Massachusetts Government

Fool.com

Moody's Gets Moody With Drugmakers

European businesses probably wish they could cut back on their imports of bad news from the U.S. this month.

Comment?

Related Topix: Biotech, Novartis, Medicine, Eli Lilly, Healthcare Industry, GlaxoSmithKline, Pfizer, Healthcare Law, Law

Tue Sep 30, 2008

Mass High Tech

Cubist expands lab research facility

Cubist Pharmaceuticals Inc. has opened its new 35,000-square-foot research facility at the company's biopharmaceutical headquarters in Lexington.

Comment?

Related Topix: Biotech, Medicine, Cubist Pharmaceuticals, Healthcare Industry

This Is Money

Astra, Pfizer get statins all-clear

Drug giants AstraZeneca and Pfizer have received a boost for their cholesterol-lowering medicines after a US report said they do not increase the risk of the neurological disorder known as Lou Gehrig's disease.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Cholesterol, Health, Lipitor, Atorvastatin (generic), Medication

Sun Sep 28, 2008

MarketWatch

Israel Stocks: Tel Aviv higher; Teva forms Japan venture, loses legal round

Israeli stocks traded broadly higher on Wednesday, led by banks, Teva Pharmaceutical Industries and real-estate companies.

Comment?

Related Topix: Biotech, Israel, World News, Teva Pharmaceutical Industries

Fri Sep 26, 2008

Med Ad News

4-Antibody Appoints Dr. Richard Mason as New Chief Executive Officer

Sep 26, 2008 - 4-Antibody AG today announced that Dr. Richard Mason has joined the company as Chief Executive Officer and Geschaeftsfuehrer.

Comment?

Related Topix: Biotech, Cambridge Antibody Technology Group, Immunology, Biology, Science, Science / Technology, Healthcare Industry

↑ Back to top

More AstraZeneca Group News

Archives

Read more articles in the AstraZeneca Group News Archives.

For up to the minute news, check out the AstraZeneca Group News Wire.

Want to add AstraZeneca Group News headlines to your web site? Get the widget here.

RSS icon mobile icon

AstraZeneca Group Photos

AstraZeneca Group News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make AstraZeneca Group News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

AstraZeneca Group Poll

created by: Bay Hiro | Jul 27, 2008

Click on an option to vote

1,564

votes

  • 50-100 miles?
  • 100-300 miles?
  • 500+ miles?

Los Angeles Jobs

Topix Extras